• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泡沫病毒载体

Foamy virus vectors.

作者信息

Mergia A, Heinkelein M

机构信息

Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.

出版信息

Curr Top Microbiol Immunol. 2003;277:131-59. doi: 10.1007/978-3-642-55701-9_6.

DOI:10.1007/978-3-642-55701-9_6
PMID:12908771
Abstract

Gene therapy is a promising novel treatment for a variety of human diseases. Successful application of gene therapy requires the availability of vehicles with the ability to efficiently deliver and express genes. Viral vectors are efficient means of transferring a gene of interest into target cells. Current available vehicles for gene transfer are either inefficient or potentially unsafe for human gene therapy applications. Foamy viruses offer a fresh alternative vector system for gene transfer with the potential to overcome the concerns of the current vectors. Foamy viruses are nonpathogenic and have a broad host range with the ability to infect various types of cells from different species. Foamy virus replication is distinct and may provide an edge for foamy virus vector usage over other retroviral vectors. These features offer the foamy vectors unique opportunities to deliver several genes into a number of different cell types in vivo safely and efficiently. The principal problems for the design of foamy virus vectors have been solved, and several foamy virus vectors that efficiently transduce a variety of cell types are available. This chapter reviews specific features of foamy virus vector systems and recent advances in the development and use of these vectors.

摘要

基因治疗是一种针对多种人类疾病的很有前景的新型治疗方法。基因治疗的成功应用需要具备能够有效递送和表达基因的载体。病毒载体是将感兴趣的基因转移到靶细胞中的有效手段。目前可用于基因转移的载体对于人类基因治疗应用而言,要么效率低下,要么存在潜在的安全性问题。泡沫病毒为基因转移提供了一种全新的替代载体系统,有可能克服当前载体所存在的问题。泡沫病毒无致病性,宿主范围广泛,能够感染来自不同物种的各种类型细胞。泡沫病毒的复制方式独特,与其他逆转录病毒载体相比,这可能是其作为载体使用的一个优势。这些特性为泡沫病毒载体提供了独特机遇,使其能够在体内安全、高效地将多个基因递送至多种不同类型的细胞。泡沫病毒载体设计的主要问题已得到解决,现已具备多种能够有效转导多种细胞类型的泡沫病毒载体。本章综述了泡沫病毒载体系统的具体特性以及这些载体在研发和应用方面的最新进展。

相似文献

1
Foamy virus vectors.泡沫病毒载体
Curr Top Microbiol Immunol. 2003;277:131-59. doi: 10.1007/978-3-642-55701-9_6.
2
Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.泡沫病毒载体:γ逆转录病毒载体和慢病毒载体期待已久的替代方案。
Curr Gene Ther. 2007 Aug;7(4):261-71. doi: 10.2174/156652307781369092.
3
Lentivirus and foamy virus vectors: novel gene therapy tools.慢病毒载体和泡沫病毒载体:新型基因治疗工具。
Expert Opin Biol Ther. 2001 Jan;1(1):17-40. doi: 10.1517/14712598.1.1.17.
4
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.泡沫病毒载体在其长末端重复序列中携带一种强大的绝缘子,可降低其基因毒性潜力。
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01639-17. Print 2018 Jan 1.
5
The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.1型猿猴泡沫病毒载体(SFV-1)在非分裂细胞和人外周血淋巴细胞中的效率。
Virology. 2001 Feb 15;280(2):243-52. doi: 10.1006/viro.2000.0773.
6
Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.表达抗HIV转基因的泡沫病毒载体可有效阻断HIV-1复制。
Mol Ther. 2008 Jan;16(1):46-51. doi: 10.1038/sj.mt.6300335. Epub 2007 Oct 23.
7
Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.表达小干扰RNA的泡沫病毒载体对猿猴免疫缺陷病毒的抑制作用。
Virology. 2005 Dec 20;343(2):275-82. doi: 10.1016/j.virol.2005.08.038. Epub 2005 Sep 21.
8
Development of foamy virus vectors.泡沫病毒载体的开发。
Methods Mol Med. 2003;76:545-64. doi: 10.1385/1-59259-304-6:545.
9
Regulation of gene expression by human foamy virus and potentials of foamy viral vectors.
Stem Cells. 1997;15 Suppl 1:141-7. doi: 10.1002/stem.5530150818.
10
Foamy virus vectors.泡沫病毒载体
J Virol. 1996 Jan;70(1):217-22. doi: 10.1128/JVI.70.1.217-222.1996.

引用本文的文献

1
Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.泡沫病毒载体在其长末端重复序列中携带一种强大的绝缘子,可降低其基因毒性潜力。
J Virol. 2017 Dec 14;92(1). doi: 10.1128/JVI.01639-17. Print 2018 Jan 1.
2
Nuclear localization signals in prototype foamy viral integrase for successive infection and replication in dividing cells.原型泡沫病毒整合酶中的核定位信号,用于在分裂细胞中进行连续感染和复制。
Mol Cells. 2014 Feb;37(2):140-8. doi: 10.14348/molcells.2014.2331. Epub 2014 Feb 19.
3
Viral and nonviral delivery systems for gene delivery.
用于基因递送的病毒和非病毒递送系统。
Adv Biomed Res. 2012;1:27. doi: 10.4103/2277-9175.98152. Epub 2012 Jul 6.
4
Advances in Gene Delivery Systems.基因递送系统的进展
Pharmaceut Med. 2011 Oct 1;25(5):293-306. doi: 10.2165/11594020-000000000-00000.
5
Development of viral vectors for gene therapy for chronic pain.用于慢性疼痛基因治疗的病毒载体的研发。
Pain Res Treat. 2011;2011:968218. doi: 10.1155/2011/968218. Epub 2011 Apr 7.
6
Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication.类反转录病毒样泡沫病毒 Gag-Pol 表达与病毒复制兼容。
Retrovirology. 2011 Aug 15;8:66. doi: 10.1186/1742-4690-8-66.
7
Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.利用 PGK 启动子表达 CD18 的泡沫病毒载体治疗犬白细胞黏附缺陷症。
Gene Ther. 2011 Jun;18(6):553-9. doi: 10.1038/gt.2010.169. Epub 2011 Jan 13.
8
The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.泡沫病毒基因组在 G1/S 期阻滞细胞的核内保持未整合状态,整合酶对于前整合复合物向核内的转运至关重要。
J Virol. 2010 Mar;84(6):2832-42. doi: 10.1128/JVI.02435-09. Epub 2009 Dec 23.
9
Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.逆转录病毒蛋白酶对1型切割位点氨基端位置的氨基酸偏好性。
J Virol. 2008 Oct;82(20):10111-7. doi: 10.1128/JVI.00418-08. Epub 2008 Aug 13.
10
Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.原型泡沫病毒包膜糖蛋白受体结合域的特性分析
J Virol. 2006 Aug;80(16):8158-67. doi: 10.1128/JVI.00460-06.